Drug class
Centrally acting non-opioid analgesic; benzoxazocine derivative
Mechanism of action
The precise mechanism is not fully established. Nefopam inhibits reuptake of serotonin, noradrenaline and dopamine and also modulates neuronal sodium and calcium channels, reducing central nociceptive transmission. It does not act through opioid receptors and does not produce the typical opioid respiratory-depressant mechanism.
General use cases
- Relief of acute and chronic pain, including postoperative, dental, musculoskeletal, traumatic and cancer pain, according to the authorised product label.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
